Future growth expectations in sales/revenue/volumes?

New start-ups onboarded are unlikely to impact near-term growth due to the company's long investment horizon. Older start-ups have matured, showing continual growth with some at inflection points, potentially driving valuation increases based on actual transactions. Revenue growth is expected from enhanced product development and market expansion, especially in data science, AI, and enterprise segments. Products like DocuXray and RELY are gaining traction, unlocking new revenue streams, particularly in corporate sectors. The company aims for EBITDA profitability soon, leveraging increased mark

Future growth expectations in earnings/operating earnings/profits/EPS?

New start-ups onboarded unlikely to impact near-term given investment time horizon; focus is on mid-to-late stage mature start-ups showing continual growth. Valuations are conservative, based on actual transactions, implying potential rise in value without additional cost. Continuous investment in product development planned over next 2-3 years to stay current and increase market coverage. Expected profitability and growth to come from increased revenues, which will also fund faster product development and market share expansion. Data science and AI product revenues anticipated to gradually ga

Current/ Expected Orderbook/ Pending Orders?

Several Proofs of Concept (POCs) have been conducted, with 2 to 3 POCs ongoing. Some smaller projects have been successfully converted to monetized orders. Post-POC, the process to ratify and adopt solutions into viable products takes additional time. The company is working on onboarding new logos, focusing initially on BFI segment and real estate compliance. RELY platform has a growing pipeline several times the current user base, with late-stage negotiations expected to convert into orders in the coming quarters. Contracts typically are annual or minimum 2-year SaaS subscription models. The

Any current/future new fundraising through debt or equity?

The transcript does not explicitly mention any ongoing or planned new fundraising through debt or equity. The company indicates having a current runway of about 10 to 12 months (Page 13). Management emphasizes a focus on achieving EBITDA profitability soon, driven by scaling up their own products (DocuXray, RELY) rather than new startup investments (Page 6, 13). There is mention of cautious investment in start-ups only if exceptionally good opportunities arise (Page 6). No direct confirmation or details provided about fresh fundraising plans in this call. Overall, the management appears focuse

Xelpmoc DesignQ4 FY26

Xelpmoc Design Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹82.1Market Cap: ₹114 Cr

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

→New start-ups onboarded are unlikely to impact near-term growth due to the company's long investment horizon.
→Older start-ups have matured, showing continual growth with some at inflection points, potentially driving valuation increases based on actual transactions.
→Revenue growth is expected from enhanced product development and market expansion, especially in data science, AI, and enterprise segments.
→Products like DocuXray and RELY are gaining traction, unlocking new revenue streams, particularly in corporate sectors.
→The company aims for EBITDA profitability soon, leveraging increased market coverage and reinvestment in product development.
→Sales teams are currently supplemented by GTM companies on contractual revenue-share models, with no immediate internal hiring.
→Runway sufficient for 10-12 months supports focused growth efforts.
→Milestones include POCs converting to orders, onboarding new enterprise clients, and capitalizing on technological advantages like edge computing and privacy-focused AI solutions.

Margin guidance

→New start-ups onboarded unlikely to impact near-term given investment time horizon; focus is on mid-to-late stage mature start-ups showing continual growth.
→Valuations are conservative, based on actual transactions, implying potential rise in value without additional cost.
→Continuous investment in product development planned over next 2-3 years to stay current and increase market coverage.
→Expected profitability and growth to come from increased revenues, which will also fund faster product development and market share expansion.
→Data science and AI product revenues anticipated to gradually gain traction over coming quarters with interest from corporate clients.
→Runway available for about 10-12 months to support growth initiatives.
→Long-term focus remains on start-up investments and product-based revenue growth; EBITDA profitability targeted as soon as new products gain traction.
→Patience emphasized; some start-ups and products may take 3-4 years to mature; partial exits (e.g., Mihup) indicate potential for returns.

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript does not explicitly mention any ongoing or planned new fundraising through debt or equity.
→The company indicates having a current runway of about 10 to 12 months (Page 13).
→Management emphasizes a focus on achieving EBITDA profitability soon, driven by scaling up their own products (DocuXray, RELY) rather than new startup investments (Page 6, 13).
→There is mention of cautious investment in start-ups only if exceptionally good opportunities arise (Page 6).
→No direct confirmation or details provided about fresh fundraising plans in this call.
→Overall, the management appears focused on organic growth and improving product monetization over new capital raises at this time.

Order book

→Several Proofs of Concept (POCs) have been conducted, with 2 to 3 POCs ongoing.
→Some smaller projects have been successfully converted to monetized orders.
→Post-POC, the process to ratify and adopt solutions into viable products takes additional time.
→The company is working on onboarding new logos, focusing initially on BFI segment and real estate compliance.
→RELY platform has a growing pipeline several times the current user base, with late-stage negotiations expected to convert into orders in the coming quarters.
→Contracts typically are annual or minimum 2-year SaaS subscription models.
→The company anticipates more order conversions and revenue recognition in the next 2 to 3 quarters as projects move beyond POC stage.
→Market cycles and client decisions contribute to the timeline of order finalization and adoption.

Capex plans

- Xelpmoc is continuously investing in product development over the next 2-3 years to stay current and competitive. - Focus remains on enhancing and scaling their own products like DocuXray (document processing AI platform) and RELY (Agetech platform), which have shown good traction. - No active onboarding of new startups currently unless exceptional opportunities arise. - They are leveraging contractual partnerships with GTM (Go-To-Market) companies instead of expanding internal sales teams, indicating strategic cost management. - The company is committed to reaching EBITDA profitability soon, supported by investments in scalable enterprise-ready AI/data science solutions. - Start-up investments remain part of the business DNA, but new investments will be selective and timed according to market environment. - Current runway available is approximately 10 to 12 months, indicating careful capital deployment. Overall, strategic investments focus on product innovation and selective partnerships rather than aggressive capital or startup investments at this point.

How does Xelpmoc Design rank vs peers in ?

Pro feature

1Xelpmoc Design

See full sector rankings

Xelpmoc DesignQ4 FY26

Xelpmoc Design Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹82.1Market Cap: ₹114 Cr

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

→New start-ups onboarded are unlikely to impact near-term growth due to the company's long investment horizon.
→Older start-ups have matured, showing continual growth with some at inflection points, potentially driving valuation increases based on actual transactions.
→Revenue growth is expected from enhanced product development and market expansion, especially in data science, AI, and enterprise segments.
→Products like DocuXray and RELY are gaining traction, unlocking new revenue streams, particularly in corporate sectors.
→The company aims for EBITDA profitability soon, leveraging increased market coverage and reinvestment in product development.
→Sales teams are currently supplemented by GTM companies on contractual revenue-share models, with no immediate internal hiring.
→Runway sufficient for 10-12 months supports focused growth efforts.
→Milestones include POCs converting to orders, onboarding new enterprise clients, and capitalizing on technological advantages like edge computing and privacy-focused AI solutions.

Margin guidance

→New start-ups onboarded unlikely to impact near-term given investment time horizon; focus is on mid-to-late stage mature start-ups showing continual growth.
→Valuations are conservative, based on actual transactions, implying potential rise in value without additional cost.
→Continuous investment in product development planned over next 2-3 years to stay current and increase market coverage.
→Expected profitability and growth to come from increased revenues, which will also fund faster product development and market share expansion.
→Data science and AI product revenues anticipated to gradually gain traction over coming quarters with interest from corporate clients.
→Runway available for about 10-12 months to support growth initiatives.
→Long-term focus remains on start-up investments and product-based revenue growth; EBITDA profitability targeted as soon as new products gain traction.
→Patience emphasized; some start-ups and products may take 3-4 years to mature; partial exits (e.g., Mihup) indicate potential for returns.

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript does not explicitly mention any ongoing or planned new fundraising through debt or equity.
→The company indicates having a current runway of about 10 to 12 months (Page 13).
→Management emphasizes a focus on achieving EBITDA profitability soon, driven by scaling up their own products (DocuXray, RELY) rather than new startup investments (Page 6, 13).
→There is mention of cautious investment in start-ups only if exceptionally good opportunities arise (Page 6).
→No direct confirmation or details provided about fresh fundraising plans in this call.
→Overall, the management appears focused on organic growth and improving product monetization over new capital raises at this time.

Order book

→Several Proofs of Concept (POCs) have been conducted, with 2 to 3 POCs ongoing.
→Some smaller projects have been successfully converted to monetized orders.
→Post-POC, the process to ratify and adopt solutions into viable products takes additional time.
→The company is working on onboarding new logos, focusing initially on BFI segment and real estate compliance.
→RELY platform has a growing pipeline several times the current user base, with late-stage negotiations expected to convert into orders in the coming quarters.
→Contracts typically are annual or minimum 2-year SaaS subscription models.
→The company anticipates more order conversions and revenue recognition in the next 2 to 3 quarters as projects move beyond POC stage.
→Market cycles and client decisions contribute to the timeline of order finalization and adoption.

Capex plans

How does Xelpmoc Design rank vs peers in ?

Pro feature

1Xelpmoc Design

See full sector rankings

Xelpmoc Design Q4 FY26 Earnings Call Analysis

Revenue guidance

Margin guidance

Fundraise plans

Order book

Capex plans

Xelpmoc Design Q4 FY26 Earnings Call Analysis

Revenue guidance

Margin guidance

Fundraise plans

Order book

Capex plans

Continue your research

What Xelpmoc Design's management said in earlier quarters